Reporting in Nature, Kumar and colleagues have now developed a method to target small-interfering RNA (siRNA) to the CNS, providing a safe and non-invasive approach for the delivery of this new ...

This report provides insights for biotech and pharmaceutical companies leveraging RNA-based precision medicine to ... to accelerate the development of siRNA therapeutics. Unlocking the Potential ...

This report provides insights for biotech and pharmaceutical companies leveraging RNA-based precision medicine to ... en/ Unlocking the Potential of siRNA for Drug Development siRNA therapeutics ...

In a mouse model, a single dose of ATL-201 durably suppressed seizures and improved behavior through six months, according to the firm.

A team from the University Medicine Würzburg, Germany, has now found a promising strategy against fungal infections. They report their findings in Nanoscale ("Enhanced antifungal activity of ...